We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Detection of Anti-Leishmanial Antibodies in Patients' Sera

By LabMedica International staff writers
Posted on 21 Jan 2009
Print article
Diagnostic method using chemiluminescence and optical fiber immunosensor (OFIS) assays were evaluated for detecting anti-leishmanial antibodies in patients' sera. Leishmaniasis is a vector-borne disease caused by a flagellated protozoan parasite of the genus Leishmania, which affects both humans and animals.

Several serological tests are available for leishmaniasis including the indirect fluorescent antibody test (IFA), and enzyme-linked immunosorbant assay (ELISA), but each has limited sensitivity and specificity. Early infection with cutaneous leishmaniasis (CL) is associated with such a low level of antibody activity that it is sometimes undetectable.

Scientists from the Shraga Segal department of microbiology and immunology, the Ben Gurion University of the Negev (Beer Sheba, Israel) compared the efficacy of a chemiluminescence-enzyme-linked immunosorbant assay and an optical fiber immunosensor (OFIS) based on chemiluminesce, for the diagnosis of leishmaniasis, using highly sensitive and specific Leishmania antigens.

They found that the chemiluminescence-ELISA was 30 times more sensitive than the colorimetric-ELISA. The highest sensitivity (x60) was observed with the OFIS. However, high cross-reactivity was observed with sera from diseases such as malaria, toxocarosis, and strongyloidiasis patients. No cross- reactivity was demonstrated with sera from patients suffering from amoebiasis, toxoplasmosis, echinococosis, enterobiasis, and schistosomiasis.

The study suggested that the OFIS technique is very sensitive for the detection of anti-leishmanial antibodies in humans. Further studies using highly purified antigens are required to clarify the usefulness of the OFIS technique for diagnosis of the disease.

The study was presented by Lilach Eliyahu at the annual meeting of the Israel Society of Parasitology, Protozoology, and Tropical Medicine, which was held in Ramat Gan, Israel on December 17, 2008.

Related Links:

Ben Gurion University of the Negev



New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.